The Cardiothoracic Surgery Department conducts a robust clinical trials program to evaluate the effectiveness of new treatments and medications that have the potential to improve the management of patients with heart, lung, and esophageal disease. The outcomes of heart, lung, and esophageal operations can be improved with technical innovations.
Immune Cells Recruited to Support Lung Cancer Growth Could Offer New Drug Targets More
Understanding Crosstalk in Tumor Microenvironment Could Lead to New Precision Medicine Approaches More
BREATHE EASY: State-of-the-Art Lung Cancer Screening & Treatment - Dr. Nasser Altorki More
Tumor Microenvironment - New York City Second Annual Symposium More